Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
XERS | Xeris Biopharma Holdings, Inc. | Director | $324K | +$10.1K | +3.21% | Jun 5, 2024 |
HZNP | Horizon Therapeutics Public Ltd Co | EVP and Chief Medical Officer | Oct 6, 2023 | |||
LRMR | Larimar Therapeutics, Inc. | Director | May 29, 2024 | |||
SBBP | Strongbridge Biopharma plc | Director | Oct 5, 2021 | |||
XERS | XERIS PHARMACEUTICALS INC | Director | Oct 5, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|